Professional Documents
Culture Documents
Tata Motors: Jaguar Land Rover - Monthly Sales Update
Tata Motors: Jaguar Land Rover - Monthly Sales Update
Tata Motors: Jaguar Land Rover - Monthly Sales Update
Tata Motors
Jaguar Land Rover Monthly sales update
Exhibit 1: JLR - wholesale volumes
Oct-12 Oct-11 chg (%) Sep-12 chg (%) YTD FY13 YTD FY12 chg (%) Jaguar Total 3,339 5,231 (36.2) 2,808 18.9 3.8 5.4 24,945 163,846 188,791 29,875 126,368 156,243 (16.5) 29.7 20.8
BUY
CMP Target Price
Investment Period
Stock Info Sector Market Cap (` cr) Net Debt (` cr) Beta 52 Week High / Low Avg. Daily Volume Face Value (`) BSE Sensex Nifty Reuters Code Bloomberg Code Automobile 72,130 12,933 1.5 321/160 1,705,763 2 16,312 5,571 TAMO.BO TTMT@IN
`264 `319
12 Months
For October 2012, Jaguar and Land Rover (JLR) posted in-line wholesale volume growth of 6.6% yoy (5.4% mom) to 27,897 units. While Jaguar sales declined 36.2% yoy (up 18.9% mom) primarily due to the impact of the hurricane Sandy in the USA; Land Rover sales registered a strong growth of 17.4% yoy (3.8% mom) backed by strong growth in Evoque, Freelander and Defender sales. Land Rover sales benefitted from the start of the third shift at the Halewood plant which eased the production constraints for Evoque (~9,500 units during the month) and Freelander models. The total volumes for the month were negatively impacted, due to the impending launch of the model year 2013 products, including new Range Rover, XF and XJ, which are slated to begin dispatches from December 2012. For instance, JLR manufactured only ~600 units of Range Rover in October 2012 as compared to ~2,500 units in October 2011.
Shareholding Pattern (%) Promoters MF / Banks / Indian Fls FII / NRIs / OCBs Indian Public / Others 34.7 12.6 44.9 7.8
3m 3.7 9.8
The volume performance for global peers like BMW and Audi remained strong in October 2012. BMWs global sales surged 15.4% yoy driven by 51.7% and 18.5% yoy growth in China and US respectively. The management expects the sales momentum to continue going ahead led by ramp-up in China and strong demand across models (mainly X1, X3, 1 and 3 series). Audi too posted a strong growth of 13.9% yoy driven by the SUV range (Q3, Q5 and Q7) and A5 models. China and US continue to drive the overall growth of the company (sales up 29.5% in China and 14.5% in US).
Yaresh Kothari
+91 22 39357800 Ext: 6844 yareshb.kothari@angelbroking.com
JLR reported a healthy retail volume growth of 10.1% yoy to 25,176 units. The volumes are not comparable on a mom basis as September tends to be exceptionally strong given change in number plates in UK. The growth was driven solely by Land Rover which registered a strong growth of 17.1% yoy to 22,166 units driven by 61.1% and 39.4% yoy growth in Evoque and Freelander sales. In terms of geography, China was the primary driver of growth as volumes surged 68.1% yoy; however, US sales declined 19.2% yoy primarily due to the impact of hurricane Sandy. Jaguar sales posted a decline of 23.6% yoy to 3,010 units as introduction of the 2013 model year products later in the year impacted the sales across geographies.
17.1 30,652
XF
New XJ
XK
Range Rover
13.5 12,609
14.1
14.3
33.9
34.2
18.9
18.0
17.5
17.7
25.9
16.6
18.5
Dec-11
Mar-12
Aug-12
Apr-12
Oct-11
Jul-12
Feb-12
Nov-11
May-12
Asia Pacific
China Region
Europe
North America
UK
Outlook and valuation: We retain our positive view on JLR and expect a 12%
volume CAGR over FY2012-14E driven by Evoque and new product launches (Range Rover, Range Rover Sport, Jaguar XF Sportbrake and all-wheel drive and smaller engine options in the XF and XJ models). Further, favorable market and product-mix and stable commodity prices will help mitigate raw-material cost pressures. We maintain our Buy rating on Tata Motors with a sum-of-the-parts (SOTP) target price of `319.
Sep-12
Oct-12
Jan-12
Jun-12
E-mail: research@angelbroking.com
Website: www.angelbroking.com
DISCLAIMER
This document is solely for the personal information of the recipient, and must not be singularly used as the basis of any investment decision. Nothing in this document should be construed as investment or financial advice. Each recipient of this document should make such investigations as they deem necessary to arrive at an independent evaluation of an investment in the securities of the companies referred to in this document (including the merits and risks involved), and should consult their own advisors to determine the merits and risks of such an investment. Angel Broking Limited, its affiliates, directors, its proprietary trading and investment businesses may, from time to time, make investment decisions that are inconsistent with or contradictory to the recommendations expressed herein. The views contained in this document are those of the analyst, and the company may or may not subscribe to all the views expressed within. Reports based on technical and derivative analysis center on studying charts of a stock's price movement, outstanding positions and trading volume, as opposed to focusing on a company's fundamentals and, as such, may not match with a report on a company's fundamentals. The information in this document has been printed on the basis of publicly available information, internal data and other reliable sources believed to be true, but we do not represent that it is accurate or complete and it should not be relied on as such, as this document is for general guidance only. Angel Broking Limited or any of its affiliates/ group companies shall not be in any way responsible for any loss or damage that may arise to any person from any inadvertent error in the information contained in this report. Angel Broking Limited has not independently verified all the information contained within this document. Accordingly, we cannot testify, nor make any representation or warranty, express or implied, to the accuracy, contents or data contained within this document. While Angel Broking Limited endeavours to update on a reasonable basis the information discussed in this material, there may be regulatory, compliance, or other reasons that prevent us from doing so. This document is being supplied to you solely for your information, and its contents, information or data may not be reproduced, redistributed or passed on, directly or indirectly. Angel Broking Limited and its affiliates may seek to provide or have engaged in providing corporate finance, investment banking or other advisory services in a merger or specific transaction to the companies referred to in this report, as on the date of this report or in the past. Neither Angel Broking Limited, nor its directors, employees or affiliates shall be liable for any loss or damage that may arise from or in connection with the use of this information. Note: Please refer to the important `Stock Holding Disclosure' report on the Angel website (Research Section). Also, please refer to the latest update on respective stocks for the disclosure status in respect of those stocks. Angel Broking Limited and its affiliates may have investment positions in the stocks recommended in this report.
Disclosure of Interest Statement 1. Analyst ownership of the stock 2. Angel and its Group companies ownership of the stock 3. Angel and its Group companies' Directors ownership of the stock 4. Broking relationship with company covered
Tata Motors No No No No
Note: We have not considered any Exposure below ` 1 lakh for Angel, its Group companies and Directors
Ratings (Returns):
6th Floor, Ackruti Star, Central Road, MIDC, Andheri (E), Mumbai- 400 093. Tel: (022) 39357800
Research Team Fundamental: Sarabjit Kour Nangra Vaibhav Agrawal Bhavesh Chauhan Viral Shah Sharan Lillaney V Srinivasan Yaresh Kothari Ankita Somani Sourabh Taparia Bhupali Gursale Vinay Rachh Amit Patil Shareen Batatawala Twinkle Gosar Tejashwini Kumari Technicals: Shardul Kulkarni Sameet Chavan Sacchitanand Uttekar Derivatives: Siddarth Bhamre Institutional Sales Team: Mayuresh Joshi Hiten Sampat Meenakshi Chavan Gaurang Tisani Akshay Shah Production Team: Tejas Vahalia Dilip Patel Research Editor Production tejas.vahalia@angelbroking.com dilipm.patel@angelbroking.com VP - Institutional Sales Sr. A.V.P- Institution sales Dealer Dealer Sr. Executive mayuresh.joshi@angelbroking.com hiten.sampat@angelbroking.com meenakshis.chavan@angelbroking.com gaurangp.tisani@angelbroking.com akshayr.shah@angelbroking.com Head - Derivatives siddarth.bhamre@angelbroking.com Sr. Technical Analyst Technical Analyst Technical Analyst shardul.kulkarni@angelbroking.com sameet.chavan@angelbroking.com sacchitanand.uttekar@angelbroking.com VP-Research, Pharmaceutical VP-Research, Banking Sr. Analyst (Metals & Mining) Sr. Analyst (Infrastructure) Analyst (Mid-cap) Analyst (Cement, Power, FMCG) Analyst (Automobile) Analyst (IT, Telecom) Analyst (Banking) Economist Research Associate Research Associate Research Associate Research Associate Research Associate sarabjit@angelbroking.com vaibhav.agrawal@angelbroking.com bhaveshu.chauhan@angelbroking.com viralk.shah@angelbroking.com sharanb.lillaney@angelbroking.com v.srinivasan@angelbroking.com yareshb.kothari@angelbroking.com ankita.somani@angelbroking.com sourabh.taparia@angelbroking.com bhupali.gursale@angelbroking.com vinay.rachh@angelbroking.com amit.patil@angelbroking.com shareen.batatawala@angelbroking.com gosar.twinkle@angelbroking.com tejashwini.kumari@angelbroking.com
Angel Broking Ltd: BSE Sebi Regn No : INB 010996539 / CDSL Regn No: IN - DP - CDSL - 234 - 2004 / PMS Regn Code: PM/INP000001546 Angel Securities Ltd:BSE: INB010994639/INF010994639 NSE: INB230994635/INF230994635 Membership numbers: BSE 028/NSE:09946 Angel Capital & Debt Market Ltd: INB 231279838 / NSE FNO: INF 231279838 / NSE Member code -12798 Angel Commodities Broking (P) Ltd: MCX Member ID: 12685 / FMC Regn No: MCX / TCM / CORP / 0037 NCDEX : Member ID 00220 / FMC Regn No: NCDEX / TCM / CORP / 0302